Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
US Army
Fuji
Farmers Insurance
Moodys
Chubb
QuintilesIMS
Fish and Richardson
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017378

« Back to Dashboard

NDA 017378 describes PLASMA-LYTE A IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the PLASMA-LYTE A IN PLASTIC CONTAINER profile page.

The generic ingredient in PLASMA-LYTE A IN PLASTIC CONTAINER is magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are one hundred and thirty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
Suppliers and Packaging for NDA: 017378
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 017378 NDA Baxter Healthcare Corporation 0338-0179 0338-0179-03 500 mL in 1 BAG (0338-0179-03)
PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate INJECTABLE;INJECTION 017378 NDA Baxter Healthcare Corporation 0338-0179 0338-0179-04 1000 mL in 1 BAG (0338-0179-04)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Approval Date:Nov 22, 1982TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Federal Trade Commission
Queensland Health
Harvard Business School
Deloitte
QuintilesIMS
US Department of Justice
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot